AI assistant
Sending…
Lexaria Bioscience Corp. — Director's Dealing 2010
Jan 26, 2010
34983_dirs_2010-01-26_74a5402b-3843-4849-9ba2-5129a6f74a12.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: LEXARIA CORP. (LXRP)
CIK: 0001348362
Period of Report: 2010-01-20
Reporting Person: DEMARTINI DAVID (Director, 10% Owner)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2010-01-20 | stock options | $0.20 | P | 100000 | Acquired | 2015-01-20 | common stock (100000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| common stock | 1600000 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Warrants | $0.2 | 2011-07-11 | common stock (1500000) | 1500000 | Direct |
| Warrants | $0.22 | 2010-12-24 | common stock (50000) | 50000 | Direct |
| Stock Options | $0.20 | 2011-07-20 | common stock (6250) | 6250 | Direct |
Footnotes
F1: Canadian dollars
More from Lexaria Bioscience Corp.
Interim / Quarterly Report
2026
Apr 13
Director's Dealing
2026
Mar 18
Delisting Announcement
2026
Feb 6
Regulatory Filings
2026
Jan 28
Declaration of Voting Results & Voting Rights Announcements
2026
Jan 28
Capital/Financing Update
2026
Jan 14
Delisting Announcement
2026
Jan 14
Interim / Quarterly Report
2026
Jan 13
Capital/Financing Update
2025
Dec 29
Regulatory Filings
2025
Dec 19